NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Net Asset Momentum
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) recorded a net asset momentum of 162.7% as of December 2024, with net assets of $757.50 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is NewAmsterdam Pharma Company N.V. Ordinar's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
NewAmsterdam Pharma Company N.V. Ordinary Shares Net Asset Momentum (2020–2024)
This chart tracks NewAmsterdam Pharma Company N.V. Ordinary Shares's year-over-year net asset growth across 5 annual reporting periods from 2020 to 2024. The most recent momentum reading is +162.7%, with net assets of $757.50 Million USD as of December 2024. For live market cap and overall valuation, see NAMS company net worth.
Annual Net Asset History for NewAmsterdam Pharma Company N.V. Ordinary Shares (2020–2024)
The table below shows the complete annual net asset history for NewAmsterdam Pharma Company N.V. Ordinary Shares from 2020 to 2024, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible equity quality of NewAmsterdam Pharma Company N.V. Ordinar to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $757.50 Million | $864.62 Million | $107.12 Million | ▲ +162.7% |
| 2023 | $288.39 Million | $347.10 Million | $58.70 Million | ▼ -32.9% |
| 2022 | $430.07 Million | $478.50 Million | $48.43 Million | ▲ +659.5% |
| 2021 | $56.63 Million | $67.99 Million | $11.36 Million | ▼ -55.6% |
| 2020 | $127.46 Million | $139.87 Million | $12.41 Million | — |